You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Details for Patent: 10,278,937


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,278,937 protect, and when does it expire?

Patent 10,278,937 protects VASCEPA and is included in one NDA.

This patent has seventy-one patent family members in thirty-nine countries.

Summary for Patent: 10,278,937
Title:Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
Abstract: In various embodiments, the present invention provides methods of reducing the risk of a cardiovascular event in a subject on statin therapy and, in particular, a method of reducing the risk of a cardiovascular event in a subject on statin therapy having a fasting baseline triglyceride level of about 135 mg/dL to about 500 mg/dL, and administering to the subject a pharmaceutical composition comprising about 1 g to about 4 g of eicosapentaenoic acid ethyl ester or a derivative thereof.
Inventor(s): Soni; Paresh (Mystic, CT)
Assignee: Amarin Pharmaceuticals Ireland Limited (Dublin, IE)
Application Number:16/006,003
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 10,278,937

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 10,278,937, using it as a case study to explain the key concepts and tools involved in patent analysis.

What is a Patent?

A patent is a form of intellectual property that grants the owner exclusive rights to make, use, sell, and distribute an invention for a specified period, typically 20 years from the filing date. The U.S. Patent and Trademark Office (USPTO) is responsible for granting U.S. patents and registering trademarks[2].

Patent Search and Analysis Tools

Before diving into the specifics of a patent, it is essential to know how to find and analyze patents. The USPTO provides several tools for this purpose:

Patent Public Search

This tool offers modern interfaces to search prior art and access enhanced patent search capabilities. It replaced legacy tools like PubEast, PubWest, PatFT, and AppFT[1].

Global Dossier

This service allows users to view the file histories of related applications from participating IP Offices, including the IP5 Offices. It provides access to the patent family, dossier, classification, and citation data[1].

Patent and Trademark Resource Centers (PTRCs)

These centers offer local search resources and training in patent search techniques, making them valuable for those new to patent searching[1].

Understanding Patent Claims

Patent claims are the heart of a patent, defining the scope of the invention. Here are some key points to consider:

Independent and Dependent Claims

Independent claims stand alone and define the invention without reference to other claims. Dependent claims, on the other hand, refer back to and further limit an independent claim[3].

Claim Length and Count

Research has shown that narrower claims, measured by claim length and count, are associated with a higher probability of grant and a shorter examination process. The examination process often narrows the scope of patent claims[3].

Analyzing United States Patent 10,278,937

Patent Title and Abstract

To begin, look at the title and abstract of the patent. These provide a brief overview of the invention.

Claims Section

The claims section is where the legal boundaries of the invention are defined. Here, you will find both independent and dependent claims.

Example of Independent Claim

An independent claim might read: "A method for [briefly describe the method], comprising: [list the steps or elements of the method]."

Example of Dependent Claim

A dependent claim might read: "The method of claim 1, wherein [add additional limitations or features]."

Description and Drawings

The description section provides a detailed explanation of the invention, often accompanied by drawings or diagrams. This section helps in understanding how the invention works and its various embodiments.

Prior Art and Citations

The prior art section and citations indicate what existing knowledge the invention builds upon. Tools like the Common Citation Document (CCD) can help consolidate citation data from multiple offices[1].

Patent Scope and Breadth

The scope of a patent is a critical aspect, as it determines the extent of protection granted.

Metrics for Measuring Patent Scope

Researchers use metrics such as independent claim length and count to measure patent scope. Narrower claims are generally associated with higher grant probabilities and shorter examination times[3].

Impact on Innovation

The breadth of a patent can influence innovation. Overly broad patents can lead to increased licensing and litigation costs, potentially diminishing incentives for innovation[3].

Continuation Procedures and Allowance Rates

Understanding continuation procedures is important for tracking the lifecycle of a patent application.

Types of Continuations

Continuations can be non-serialized (e.g., Requests for Continued Examination) or serialized (e.g., divisional applications). These procedures can complicate the calculation of allowance rates[4].

Allowance Rates

The USPTO calculates several measures of allowance rates, including first-action allowance rate, progenitor allowance rate, and family allowance rate. These rates help in understanding the likelihood of a patent being granted[4].

International Patent Landscape

Patents are not limited to the U.S.; they can be filed and granted in various countries.

Searching International Patents

Databases like the European Patent Office's esp@cenet, the Japan Patent Office, and the World Intellectual Property Organization's PATENTSCOPE provide access to international patent collections[1].

Legal and Policy Considerations

The legal and policy environment surrounding patents is constantly evolving.

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court to address issues related to patent litigation costs and complexity[5].

Key Takeaways

  • Patent Claims: The claims section of a patent defines the legal boundaries of the invention.
  • Patent Scope: Metrics like claim length and count help measure the scope of a patent.
  • Continuation Procedures: Understanding these procedures is crucial for tracking the lifecycle of a patent application.
  • International Patents: Patents can be searched and filed internationally through various databases.
  • Legal Considerations: The legal environment, including potential reforms like a small claims patent court, can impact patent litigation and innovation.

FAQs

What is the purpose of the claims section in a patent?

The claims section defines the legal boundaries of the invention, specifying what is protected by the patent.

How do continuation procedures affect patent applications?

Continuation procedures can extend the examination process and complicate the calculation of allowance rates, but they allow applicants to refine their applications and introduce new subject matter.

What tools are available for searching international patents?

Tools like the European Patent Office's esp@cenet, the Japan Patent Office, and the World Intellectual Property Organization's PATENTSCOPE provide access to international patent collections.

Why is the scope of a patent important?

The scope of a patent determines the extent of protection granted and can influence innovation by affecting licensing and litigation costs.

What is the significance of the Common Citation Document (CCD)?

The CCD consolidates citation data from multiple offices, providing a single point of access to prior art cited by participating IP Offices.

Sources

  1. USPTO: Search for patents - USPTO
  2. USA.gov: U.S. Patent and Trademark Office (USPTO) | USAGov
  3. SSRN: Patent Claims and Patent Scope - Search eLibrary :: SSRN
  4. YJOLT: What Is the Probability of Receiving a US Patent?
  5. ACUS: U.S. Patent Small Claims Court

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,278,937

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Amarin Pharms VASCEPA icosapent ethyl CAPSULE;ORAL 202057-001 Jul 26, 2012 AB RX Yes Yes ⤷  Subscribe ⤷  Subscribe USE OF VASCEPA AS AN ADJUNCT TO STATIN THERAPY TO REDUCE THE RISK OF A CV EVENT (CV DEATH, CORONARY REVASCULARIZATION, UNSTABLE ANGINA, STROKE AND/OR MYOCARDIAL INFARCTION) IN AN ADULT PATIENT WITH ELEVATED TRIGLYCERIDE LEVELS AND DIABETES MELLITUS ⤷  Subscribe
Amarin Pharms VASCEPA icosapent ethyl CAPSULE;ORAL 202057-002 Feb 16, 2017 AB RX Yes No ⤷  Subscribe ⤷  Subscribe USE OF VASCEPA AS AN ADJUNCT TO STATIN THERAPY TO REDUCE THE RISK OF A CV EVENT (CV DEATH, CORONARY REVASCULARIZATION, UNSTABLE ANGINA, STROKE AND/OR MYOCARDIAL INFARCTION) IN AN ADULT PATIENT WITH ELEVATED TRIGLYCERIDE LEVELS AND DIABETES MELLITUS ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,278,937

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2013282394 ⤷  Subscribe
Australia 2018204499 ⤷  Subscribe
Australia 2020294210 ⤷  Subscribe
Brazil 112014032905 ⤷  Subscribe
Canada 2877514 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.